Article

New Diabetes Guidelines Have It Both Ways

A new guideline calls for a tailored approach to treating type 2 diabetes while maintaining the use of an algorithm-based model, researchers said.

The new recommendations from the American Association of Clinical Endocrinologists (AACE) offer an algorithm that involves every FDA approved class of medications for managing hyperglycemia, while still suggesting consideration of individual patient characteristics such as age and comorbidities, Alan Garber, MD, PhD, of Baylor College of Medicine in Houston, and colleagues reported in Endocrine Practice.

"The majority of patients aren't reaching goal," Garber told MedPage Today. "We think a more assertive recommendation of treatments will help physicians get patients to goal and avoid the pitfalls of certain medications."

Read the full story here: http://bit.ly/ZIBaoW

Source: MedPageToday.com

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Marry Vuong, PharmD, BCPPS
Dr Sundar Jagannath
Dr Muhammad Faizan
Andrew Kuykendall, MD, Moffitt Cancer Center
Dr Sundar Jagannath
4 experts in this video
4 experts in this video
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
World Hepatitis Day graphic | Image Credit: uazzal - stock.adobe.com
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo